Search

everythinglearnresearchcommunity

for

Search:↓

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Monoclonal antibodies are often linked to alopecia areata cases.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Systemic lupus erythematosus is managed with lifestyle changes, symptomatic treatments, and careful use of medications to control symptoms and flares.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Young adults with hair loss face higher risk of stiff arteries.

AE can have varied symptoms and genetic causes, but zinc therapy helps.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

Tph cells are linked to the severity of systemic lupus erythematosus.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

42% of SLE patients had thyroid issues, mostly hypothyroidism.

People with psoriasis have more health problems, including autoimmune diseases, than those without it.

DM and AA may share a common cause.

A woman's hair loss led to discovering she had lupus.

Relapsing polychondritis might be linked to alopecia areata due to immune system factors.

Tofacitinib is an effective and safe treatment for alopecia areata.

More effective treatments are needed for severe alopecia areata.

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.